A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

393

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Diseases, Alcoholic

Interventions

DRUG: GSK4532990
DRUG: Placebo

Sponsor

GlaxoSmithKline